Table 2.
Odds Ratios for Patient Characteristics, Chronic Liver Disease Etiologies, and Waiting List Complications among Asians and Native Hawaiians and Other Pacific Islanders Compared to Whites
| Asian OR (95% CI) | NHOPI OR (95% CI) | |
|---|---|---|
| Female | 1.21 (0.46–3.23) | 1.14 (0.31–4.19) |
| Obesity, BMI | .30 1.08 (0.37–3.30) | 9.23 (2.18–49.23)a |
| Ascites | 0.66 (0.21–1.93) | 0.80 (0.19–3.78) |
| Hepatic encephalopathy | 0.31 (0.10–0.88)a | 0.49 (0.12–2.02) |
| Variceal bleeding | 0.74 (0.26–2.15) | 0.43 (0.07–1.99) |
| Hepatitis B | 9.13 (1.21–411.71)a | 9.43 (0.97–92.07) |
| Hepatitis C | 0.55 (0.20–1.49) | 0.64 (0.16–2.39) |
| Alcoholic liver disease | 0.25 (0.81–0.74)a | 0.23 (0.05–0.92)a |
| NASH | 3.94 (0.76–39.51) | 3.12 (0.32–41.04) |
| Liver cancer | 1.55 (0.55–4.64) | 2.19 (0.56–8.67) |
| Multiple waiting list events | 0.38 (0.01–1.37) | 0.80 (0.15–3.55) |
| Death or removal on waiting list | 0.68 (0.25–1.84) | 0.56 (0.13–2.17) |
| Transplanted | 2.31 (0.88–6.25) | 0.36 (0.09–1.33) |
| Sarcopenia by SMI at L3 | 0.66 (0.23–1.81) | 0.09 (0.01–0.42)a |
| Sarcopenia by PMI at umbilicus | 1.98 (0.32–21.80) | 0.51 (0.03–7.92) |
Abbreviations: NHOPI, Native Hawaiian and Other Pacific Islander; OR, Odds ratio; 95% CI, 95% confidence interval; BMI, Body mass index; NASH, Non-alcoholic steatohepatitis; SMI, Skeletal muscle index; PMI, Psoas muscle index.
a
P<.05